Journal of Neuroscience Research · 2015 · 10 citations · 34 references
Life SciencesNeurobiologyNeuroscienceInflammationNeuroimmunologyNeuropharmacologyInflammatory ProcessesNeuroimmune RegulationNeuroinflammationReflex PhysiologyStress NeuroscienceStress-immune InteractionsAcute NeuroinflammationInflammatory ReflexNeuroinflammatory MechanismsNeuropsychiatric EffectsPrefrontal Cortex PhysiologySynaptic ExcitationTemporal CortexVagal Nerve Function
Stress is a potential trigger for a number of neuropsychiatric conditions, including anxiety syndromes and schizophrenic psychoses. The temporal neocortex is a stress-sensitive area involved in the development of such conditions. We have recently shown that aseptic inflammation and mild electric shock shift the balance between synaptic excitation and synaptic inhibition in favor of the former in this brain area (Garcia-Oscos et al., 2012), as well as in the prefrontal cortex (Garcia-Oscos et al., 2014). Given the potential clinical importance of this phenomenon in the etiology of hyperexcitable neuropsychiatric illness, this study investigates whether inactivation of the peripheral immune system by the "anti-inflammatory reflex" would reduce the central response to aseptic inflammation. For a model of aseptic inflammation, this study used i.p. injections of the bacterial toxin lipopolysaccharide (LPS; 5 µM) and activated the anti-inflammatory reflex either pharmacologically by i.p. injections of the nicotinic α7 receptor agonist PHA543613 or physiologically through electrical stimulation of the left vagal nerve (VNS). Patch-clamp recording was used to monitor synaptic function. Recordings from LPS-injected Sprague Dawley rats show that activation of the anti-inflammatory reflex either pharmacologically or by VNS blocks or greatly reduces the LPS-induced decrease of the synaptic inhibitory-to-excitatory ratio and the saturation level of inhibitory current input-output curves. Given the ample variety of pharmacologically available α7 nicotinic receptor agonists as well as the relative safety of clinical VNS already approved by the FDA for the treatment of epilepsy and depression, our findings suggest a new therapeutic avenue in the treatment of stress-induced hyperexcitable conditions mediated by a decrease in synaptic inhibition in the temporal cortex.
34
Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation
Hong Wang, Man Yu, Mahendar Ochani et al. · Nature · 2002 · 3.2K citations
Synaptic scaling mediated by glial TNF-α
David Stellwagen, Robert C. Malenka · Nature · 2006 · 1.7K citations
Control of Synaptic Strength by Glial TNFα
Eric C. Beattie, David Stellwagen, Wade Morishita et al. · Science · 2002 · 1.3K citations
Reversing pathological neural activity using targeted plasticity
Navzer D. Engineer, Jonathan Riley, Jonathan D. Seale et al. · Nature · 2011 · 689 citations